Back to companies

ORIENTBIO Inc.

002630KRKRX

오리엔트바이오

Revenue
₩28.0bn
FY2024
Operating income
-₩645.9mn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)